Back to search
Body Fat Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Body Fat Disorder trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Body Fat Disorder trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modifica…
Introduction: Sedentary behavior (SB) and insufficient physical activity (PA) interact to worsen physical fitness (PF), obesity-related complications and diseas…
Evaluate the effect of spermidine supplementation on lipid profile changes in individuals with overweight or obesity accompanied by hyperlipidemia. Analyze the…
The main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight i…
Objectives The objective of this project is to generate pilot data substantiating our hypothesis that advanced body composition measurement tools will provide m…
This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of…
The investigators are proposing a new team-based shared decision-making (SDM) program. The goal of this study is to see whether this program is practical and wh…
The objectives of this trial are to assess the effects of adding 2 servings/d of either full-fat or low-fat fermented dairy products to the diet, as a replaceme…